Understanding Tolvaptan Research
Tolvaptan is a selective vasopressin V2 receptor antagonist representing an important research tool for investigating antidiuretic hormone pathways and aquaporin regulation mechanisms. This compound demonstrates competitive inhibition of vasopressin binding to V2 receptors in renal collecting duct cells, making it valuable for studies examining water homeostasis and osmotic balance in cellular models. Centurion Laboratories provides consistent quality formulations supporting reproducible experimental outcomes across diverse research protocols. Investigators at Stroid UK Shop utilise this compound for examining vasopressin signalling cascades and aquaporin-2 trafficking mechanisms.
Laboratory Applications in Research
Research applications focus on cardiovascular and renal physiology studies where vasopressin receptor modulation provides insights into fluid retention mechanisms. Scientists examine tolvaptan’s effects on cyclic adenosine monophosphate signalling pathways and protein kinase A activation in cell culture systems. The compound enables investigation of hyponatremia correction mechanisms and osmolyte regulation in various experimental models. Comparative studies with other vasopressin receptor modulators available in our specialised pharmaceutical research section enhance understanding of selective receptor binding profiles. Researchers studying metabolic pathways often combine these investigations with selective androgen receptor modulators and peptide research compounds for comprehensive hormonal pathway analysis.
Technical Specifications
| Parameter | Specification |
|---|---|
| Chemical Name | Tolvaptan |
| CAS Number | 150683-30-0 |
| Molecular Formula | C₂₆H₂₅ClN₂O₃ |
| Molecular Weight | 448.95 g/mol |
| Dosage Form | 30mg tablets |
| Manufacturer | Centurion Laboratories |
| Storage Conditions | Room temperature, dry environment |
| Solubility | Verify with supplier |
Research Compliance Information
This tolvaptan formulation is manufactured exclusively for in-vitro laboratory research applications and is not approved for human consumption, veterinary use, or therapeutic applications. Researchers must maintain appropriate laboratory safety protocols and ensure proper waste disposal procedures when conducting experiments with vasopressin receptor antagonists. All experimental work should comply with institutional research guidelines and applicable regulatory frameworks governing research chemical handling. Purchase and use must align strictly with legitimate scientific research purposes as outlined in academic or commercial laboratory protocols.
